THYROID DISEASE / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Subacute thyroiditis (SAT) is typically a self-limiting, inflammatory disease. Patients can experience hypothyroidism during or after an episode. We examined the clinical characteristics based on laboratory and imaging studies in patients with SAT and possible factors contributing to the development of permanent hypothyroidism after SAT.

Material and methods:
We retrospectively examined the medical records of patients diagnosed with SAT at one medical facility in Turkey. Patients known to have previous thyroid disease, those with < 6 months of follow-up after resolution of SAT, and those who lacked sufficient data for analysis were excluded. Of the 283 patients identified, 119 met all the inclusion criteria. We extracted data on demographics, laboratory tests, neck pain and other symptoms, ultrasonography findings, medication use, and SAT recurrence. We examined the relationships between these variables and the development of permanent hypothyroidism.

Results:
The patients were 42 years old on average, and 78% were women. Most patients (70%) described flu-like symptoms before neck pain started; accordingly, 57% had initially visited a specialty other than endocrinology before SAT was diagnosed, and 28% had received antibiotics for misdiagnosed upper respiratory tract infection. In all, 10 patients (8.4%) developed permanent hypothyroidism after SAT. These patients had received steroids significantly longer than those without permanent hypothyroidism (mean 17.7 weeks vs. 8.9 weeks; p = 0.021). Development of hypothyroidism was significantly lower among patients with thyrotoxicosis.

Conclusions:
The diagnosis of SAT can be challenging. Patients who require longer-term steroids after SAT and who have recurrent SAT should be closely monitored for development of hypothyroidism.
REFERENCES (28)
1.
Volpé R. Subacute (de Quervain’s) thyroiditis. Clin Endocrinol Metab 1979; 8: 81-95.
 
2.
Lazarus JH. Silent thyroiditis and subacute thyroiditis. In: Braverman LE, Utiger RD (eds.). The Thyroid: A Fundamental and Clinical Text. 7th ed. Lippincott Williams & Wilkins, Philadelphia 1996; 577-91.
 
3.
Samuels MH. Subacute, silent, and postpartum thyroiditis. Med Clin North Am 2012; 96: 223-33.
 
4.
Fatourechi V, Aniszewski JP, Fatourechi GZE, Atkinson EJ, Jacobsen SJ. Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J Clin Endocrinol Metab 2003; 88: 2100-5.
 
5.
Zhao N, Wang S, Cui XJ, et al. Two-years prospective follow-up study of subacute thyroiditis. Front Endocrinol (Lausanne) 2020; 11: 47.
 
6.
Lio S, Pontecorvi A, Caruso M, Monaco F, D’Armiento M. Transitory subclinical and permanent hypothyroidism in the course of subacute thyroiditis (de Quervain). Acta Endocrinol (Copenh) 1984; 106: 67-70.
 
7.
Görges J, Ulrich J, Keck C, Müller-Wielan D, Diederich S, Janssen O. Long-term outcome of subacute thyroiditis. Exp Clin Endocrinol Diabetes 2020; 128: 703-8.
 
8.
Benbassat CA, Olchovsky D, Tsvetov G, Shimon I. Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest 2007; 30: 631-5.
 
9.
Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med 2008; 47: 725-9.
 
10.
Dulipsingh L, Ikram Z, Malchoff CD, Shoukri KC. A cluster of cases of subacute and silent thyroiditis in the northern Connecticut, Greater Hartford area. Conn Med 1998; 62: 395-7.
 
11.
Martino E, Buratti L, Bartalena L, et al. High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest 1987; 10: 321-3.
 
12.
Saito S, Sakurada T, Yamamoto M, Yamaguchi T, Yoshida K. Subacute thyroiditis: observations on 98 cases for the last 14 years. Tohoku J Exp Med 1974; 113: 141-7.
 
13.
Chen W, Tian Y, Li Z, Zhu J, Wie T, Lei J. Potential interaction between SARS-CoV-2 and thyroid: a review. Endocrinology 2021; 162: bqab004.
 
14.
Tesfaye H, Cimermanova R, Cholt M, Sykorova P, Pechova M, Prusa R. Subacute thyroiditis confused with dental problem. Cas Lek Cesk 2009; 48: 438-41.
 
15.
Cunha BA, Chak A, Strollo S. Fever of unknown origin (FUO): De Quervain’s subacute thyroiditis with highly elevated ferritin levels mimicking temporal arteritis (TA). Heart Lung 2010; 39: 73-7.
 
16.
Weiss BM, Hepburn MJ, Mong DP. Subacute thyroiditis manifesting as fever of unknown origin. South Med J 2000; 93: 926-9.
 
17.
Stasiak M, Michalak R, Stasiak B, Lewiński A. Time-lag between symptom onset and diagnosis of subacute thyroiditis. Horm Metab Res 2020; 52: 32-8.
 
18.
Bostan H, Sencar ME, Calapkulu M, et al. Two important issues in subacute thyroiditis management: delayed diagnosis and inappropriate use of antibiotics. Eur Thyroid J 2021; 10: 323-9.
 
19.
Park SY, Kim EK, Kim MJ, et al. Ultrasonographic characteristics of subacute granulomatous thyroiditis. Korean J Radiol 2006; 7: 229-34.
 
20.
Omori N, Omori K, Takano K. Association of the ultrasonographic findings of subacute thyroiditis with thyroid pain and laboratory findings. Endocr J 2008; 55: 583-8.
 
21.
Kunz A, Blank W, Braun B. De Quervain’s subacute thyroiditis – color Doppler sonography findings. Ultraschall Med 2005; 26: 102-6.
 
22.
Schenke S, Klett R, Braun S, Zimny M. Thyroiditis de Quervain. Are there predictive factors for long-term hormone-replacement? Nuklearmedizin 2013; 52: 137-40.
 
23.
Sencar ME, Calapkulu M, Sakız D, et al. The contribution of ultrasonographic findings to the prognosis of subacute thyroiditis. Arch Endocrinol Metab 2020; 64: 306-11.
 
24.
Nishihara E, Amino N, Ohye H, et al. Extent of hypoechogenic area in the thyroid is related with thyroid dysfunction after subacute thyroiditis. J Endocrinol Invest 2009; 32: 33-6.
 
25.
Bennedbaek FN, Hegedüs L. The value of ultrasonography in the diagnosis and follow-up of subacute thyroiditis. Thyroid 1997; 7: 45-50.
 
26.
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis Thyroid 2016; 26: 1343-421. Erratum: Thyroid 2017; 27: 1462.
 
27.
Saklamaz A. Is there a drug effect on the development of permanent hypothyroidism in subacute thyroiditis? Acta Endocrinologica (Buchar) 2017; 13: 119-23.
 
28.
Sencar ME, Calapkulu M, Sakiz D, et al. An evaluation of the results of the steroid and non-steroidal anti-inflammatory drug treatments in subacute thyroiditis in relation to persistent hypothyroidism and recurrence. Sci Rep 2019; 9: 16899.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top